Kang, D.W.; Kim, J.H.; Kim, K.M.; Cho, S.-j.; Jang, H.-W.; Chang, J.W.; Dong, S.M.; Lim, J.W.; Kim, J.-S.; Cho, H.-Y.
Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704. Pharmaceutics 2021, 13, 1406.
https://doi.org/10.3390/pharmaceutics13091406
AMA Style
Kang DW, Kim JH, Kim KM, Cho S-j, Jang H-W, Chang JW, Dong SM, Lim JW, Kim J-S, Cho H-Y.
Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704. Pharmaceutics. 2021; 13(9):1406.
https://doi.org/10.3390/pharmaceutics13091406
Chicago/Turabian Style
Kang, Dong Wook, Ju Hee Kim, Kyung Min Kim, Seok-jin Cho, Hee-Woon Jang, Ji Won Chang, Seung Myung Dong, Jee Woong Lim, Jae-Sun Kim, and Hea-Young Cho.
2021. "Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704" Pharmaceutics 13, no. 9: 1406.
https://doi.org/10.3390/pharmaceutics13091406
APA Style
Kang, D. W., Kim, J. H., Kim, K. M., Cho, S.-j., Jang, H.-W., Chang, J. W., Dong, S. M., Lim, J. W., Kim, J.-S., & Cho, H.-Y.
(2021). Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704. Pharmaceutics, 13(9), 1406.
https://doi.org/10.3390/pharmaceutics13091406